000 | 01995 a2200529 4500 | ||
---|---|---|---|
005 | 20250517233827.0 | ||
264 | 0 | _c20181211 | |
008 | 201812s 0 0 eng d | ||
022 | _a1422-0067 | ||
024 | 7 |
_a10.3390/ijms19092485 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHehlgans, Stephanie | |
245 | 0 | 0 |
_aRadiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib. _h[electronic resource] |
260 |
_bInternational journal of molecular sciences _cAug 2018 |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnilides _xpharmacology |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aCarcinoma, Basal Cell _xgenetics |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xgenetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCombined Modality Therapy _xmethods |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 |
_aG2 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 |
_aGamma Rays _xtherapeutic use |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xgenetics |
650 | 0 | 4 |
_aHedgehog Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aHistones _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOrgan Specificity |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xpharmacology |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aSkin Neoplasms _xgenetics |
650 | 0 | 4 |
_aSurvivin _xgenetics |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
650 | 0 | 4 |
_aZinc Finger Protein GLI1 _xgenetics |
700 | 1 | _aBooms, Patrick | |
700 | 1 | _aGüllülü, Ömer | |
700 | 1 | _aSader, Robert | |
700 | 1 | _aRödel, Claus | |
700 | 1 | _aBalermpas, Panagiotis | |
700 | 1 | _aRödel, Franz | |
700 | 1 | _aGhanaati, Shahram | |
773 | 0 |
_tInternational journal of molecular sciences _gvol. 19 _gno. 9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3390/ijms19092485 _zAvailable from publisher's website |
999 |
_c28764324 _d28764324 |